Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Mythic Therapeutics has raised $103.0M in total funding. The most recent round was Series B. The last funding was announced in December 2021.
Mythic Therapeutics's investors include BoxGroup, First Round Capital, Foresite Capital, Perceptive Advisors, Venrock.
Mythic Therapeutics is headquartered in Waltham, United States.
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Mythic Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mythic Therapeutics — Funding & Investors." VCBacked, December 15, 2021, https://www.vcbacked.co/company/mythic-therapeutics. Accessed September 14, 2026.
VCBacked. (2021). Mythic Therapeutics — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/mythic-therapeutics
{{cite web |title=Mythic Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mythic-therapeutics |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated